Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS)

Placenta

Volumn 32, Issue SUPPL. 4, 2011, Pages

  Parolini, O ^a   Alviano, F ^b   Betz, A G ^c   Bianchi, D W ^d   Gotherstrom C ^e   Manuelpillai, U ^f   Mellor, A L ^g   Ofir, R ^h   Ponsaerts, P ⁱ   Scherjon, S A ^j   Weiss, M L ^k   Wolbank, S ^l   Wood, K J ^m   Borlongan, C V ⁿ  

^a Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d TUFTS MEDICAL CENTER   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f MONASH UNIVERSITY   (Australia)

^g MEDICAL COLLEGE OF GEORGIA   (United States)

^h PLURISTEM THERAPEUTICS INC   (Israel)

ⁱ UNIVERSITY OF ANTWERP   (Belgium)

^j LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^k KANSAS STATE UNIVERSITY   (United States)

^l LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ UNIVERSITY OF SOUTH FLORIDA   (United States)

more..

Author keywords

Adult stem cells; Cell transplantation; Fetomaternal tolerance; Immunomodulation; Inflammation; Placenta; Pregnancy

Indexed keywords

CELL MIGRATION; CONFERENCE PAPER; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MEDICAL SOCIETY; MESENCHYMAL STEM CELL; NONHUMAN; PLACENTA; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TRANSPLANTATION TOLERANCE;

FEMALE; FETAL STEM CELLS; FETUS; HUMANS; PLACENTA; PREGNANCY;

EID: 80052515140     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2011.04.017     Document Type: Conference Paper

References (49)

1. P. Medawar Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates Symp Soc Exp Biol 7 1953 320 338
2. O. Parolini, F. Alviano, G.P. Bagnara, G. Bilic, H.J. Buhring, and M. Evangelista Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells Stem Cells 26 2008 300 311 (Pubitemid 351413589)
3. O. Parolini, F. Alviano, I. Bergwerf, D. Boraschi, C. De Bari, and P. De Waele Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table Stem Cells Dev 19 2010 143 154
4. D.W. Bianchi, and N.M. Fisk Fetomaternal cell trafficking and the stem cell debate: gender matters Jama 297 2007 1489 1491 (Pubitemid 46556474)
5. D.W. Bianchi, G.K. Zickwolf, G.J. Weil, S. Sylvester, and M.A. DeMaria Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum Proc Natl Acad Sci U S A 93 1996 705 708 (Pubitemid 26041153)
6. K. Khosrotehrani, K.L. Johnson, D.H. Cha, R.N. Salomon, and D.W. Bianchi Transfer of fetal cells with multilineage potential to maternal tissue Jama 292 2004 75 80 (Pubitemid 38923796)
7. B. Srivatsa, S. Srivatsa, K.L. Johnson, O. Samura, S.L. Lee, and D.W. Bianchi Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study Lancet 358 2001 2034 2038 (Pubitemid 34084826)
8. D.W. Bianchi Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease Best Pract Res Clin Obstet Gynaecol 18 2004 959 975 (Pubitemid 40012030)
9. Y. Fujiki, K.L. Johnson, I. Peter, H. Tighiouart, and D.W. Bianchi Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers Biol Reprod 81 2009 26 32
10. V.R. Aluvihare, M. Kallikourdis, and A.G. Betz Tolerance, suppression and the fetal allograft J Mol Med 83 2005 88 96 (Pubitemid 40379297)
11. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, and A.L. Mellor Inhibition of T cell proliferation by macrophage tryptophan catabolism J Exp Med 189 1999 1363 1372 (Pubitemid 29227522)
12. A.L. Mellor, P. Chandler, G.K. Lee, T. Johnson, D.B. Keskin, and J. Lee Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy J Reprod Immunol 57 2002 143 150 (Pubitemid 35245745)
13. B.A. Johnson 3rd, B. Baban, and A.L. Mellor Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy Immunotherapy 1 2009 645 661
14. L. Huang, B. Baban, B.A. Johnson 3rd, and A.L. Mellor Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege Int Rev Immunol 29 2010 133 155
15. S. Meirelles Lda, and N.B. Nardi Methodology, biology and clinical applications of mesenchymal stem cells Front Biosci 14 2009 4281 4298
16. P.S. In 't Anker, S.A. Scherjon, C. Kleijburg-van der Keur, G.M. de Groot-Swings, F.H. Claas, and W.E. Fibbe Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta Stem Cells 22 2004 1338 1345 (Pubitemid 39636409)
17. D.L. Roelen, B.J. van der Mast, P.S. in't Anker, C. Kleijburg, M. Eikmans, and E. van Beelen Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells Hum Immunol 70 2009 16 23
18. K. Le Blanc, I. Rasmusson, B. Sundberg, C. Gotherstrom, M. Hassan, and M. Uzunel Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells Lancet 363 2004 1439 1441 (Pubitemid 38586721)
19. J. Wieckiewicz, R. Goto, and K.J. Wood T regulatory cells and the control of alloimmunity: from characterisation to clinical application Curr Opin Immunol 22 2010 662 668
20. P.V. Guillot, C. Gotherstrom, J. Chan, H. Kurata, and N.M. Fisk Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC Stem Cells 25 2007 646 654 (Pubitemid 46354223)
21. C. Gotherstrom, A. Lundqvist, I.R. Duprez, R. Childs, L. Berg, and K. le Blanc Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways Cytotherapy 13 2011 269 278
22. Z.Y. Zhang, S.H. Teoh, M.S. Chong, J.T. Schantz, N.M. Fisk, and M.A. Choolani Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells Stem Cells 27 2009 126 137
23. K. Le Blanc, C. Gotherstrom, O. Ringden, M. Hassan, R. McMahon, and E. Horwitz Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta Transplantation 79 2005 1607 1614 (Pubitemid 40847594)
24. O. Parolini, M. Soncini, M. Evangelista, and D. Schmidt Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med 4 2009 275 291
25. O. Parolini, and M. Caruso Review: preclinical studies on placenta-derived cells and amniotic membrane: an update Placenta 32 Suppl. 2 2011 S186 S195
26. A. Lindenmair, S. Wolbank, G. Stadler, A. Meinl, A. Peterbauer-Scherb, and J. Eibl Osteogenic differentiation of intact human amniotic membrane Biomaterials 31 2010 8659 8665
27. M. Bailo, M. Soncini, E. Vertua, P.B. Signoroni, S. Sanzone, and G. Lombardi Engraftment potential of human amnion and chorion cells derived from term placenta Transplantation 78 2004 1439 1448 (Pubitemid 39552929)
28. M. Magatti, S. De Munari, E. Vertua, L. Gibelli, G.S. Wengler, and O. Parolini Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities Stem Cells 26 2008 182 192
29. M. Magatti, S. De Munari, E. Vertua, C. Nassauto, A. Albertini, and G.S. Wengler Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes Cell Transplant 18 2009 899 914
30. A. Cargnoni, L. Gibelli, A. Tosini, P.B. Signoroni, C. Nassuato, and D. Arienti Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis Cell Transplant 18 2009 405 422
31. A. Cargnoni, M. Di Marcello, M. Campagnol, C. Nassuato, A. Albertini, and O. Parolini Amniotic membrane patching promotes ischemic rat heart repair Cell Transplant 18 2009 1147 1159
32. L.B. Sant'anna, A. Cargnoni, L. Ressel, G. Vanosi, and O. Parolini Amniotic Membrane application reduces liver fibrosis in a Bile Duct Ligation rat model Cell Transplant 2010 Aug 18 [Epub ahead of print]
33. Y. Moodley, D. Atienza, U. Manuelpillai, C.S. Samuel, J. Tchongue, and S. Ilancheran Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury Am J Pathol 175 2009 303 313
34. Y. Moodley, S. Ilancheran, C. Samuel, V. Vaghjiani, D. Atienza, and E.D. Williams Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair Am J Respir Crit Care Med 182 2010 643 651
35. U. Manuelpillai, J. Tchongue, D. Lourensz, V. Vaghjiani, C.S. Samuel, and A. Liu Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl-treated mice Cell Transplant 19 2010 1157 1168
36. T. Miki, T. Lehmann, H. Cai, D.B. Stolz, and S.C. Strom Stem cell characteristics of amniotic epithelial cells Stem Cells 23 2005 1549 1559 (Pubitemid 41741004)
37. F. Alviano, V. Fossati, C. Marchionni, M. Arpinati, L. Bonsi, and M. Franchina Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro BMC Dev Biol 7 2007 11
38. M.L. Weiss, C. Anderson, S. Medicetty, K.B. Seshareddy, R.J. Weiss, and I. VanderWerff Immune properties of human umbilical cord Wharton's jelly-derived cells Stem Cells 26 2008 2865 2874
39. T. Deuse, M. Stubbendorff, K. Tang-Quan, N. Phillips, M.A. Kay, and T. Eiermann Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells Cell Transplant 2010 Nov 5 [Epub ahead of print]
40. M. Najar, G. Raicevic, H.I. Boufker, H. Fayyad Kazan, C. De Bruyn, and N. Meuleman Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources Cell Immunol 264 2010 171 179
41. S.J. Prasanna, D. Gopalakrishnan, S.R. Shankar, and A.B. Vasandan Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially PLoS One 5 2010 e9016
42. K.H. Yoo, I.K. Jang, M.W. Lee, H.E. Kim, M.S. Yang, and Y. Eom Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues Cell Immunol 259 2009 150 156
43. K.P. Reekmans, J. Praet, N. De Vocht, B.R. Tambuyzer, I. Bergwerf, and J. Daans Clinical potential of intravenous neural stem cell delivery for treatment of neuro-inflammatory disease in mice? Cell Transplant 2010 Nov 19 [Epub ahead of print]
44. N. De Vocht, I. Bergwerf, G. Vanhoutte, J. Daans, G. De Visscher, and S. Chatterjee Labeling of Luciferase/eGFP-Expressing bone marrow-derived stromal cells with fluorescent Micron-Sized Iron Oxide Particles improves Quantitative and Qualitative Multimodal imaging of cellular grafts in vivo Mol Imaging Biol 2011 Jan 19 [Epub ahead of print]
45. B.R. Tambuyzer, I. Bergwerf, N. De Vocht, K. Reekmans, J. Daans, and P.G. Jorens Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation Immunol Cell Biol 87 2009 267 273
46. I. Bergwerf, B. Tambuyzer, N. De Vocht, K. Reekmans, J. Praet, and J. Daans Recognition of cellular implants by the brain's innate immune system Immunol Cell Biol 2011 Nov 23 [Epub ahead of print]
47. C.V. Borlongan Cell therapy for stroke: remaining issues to address before embarking on clinical trials Stroke 40 2009 S146 S148
48. S.J. Yu, M. Soncini, Y. Kaneko, D.C. Hess, O. Parolini, and C.V. Borlongan Amnion: a potent graft source for cell therapy in stroke Cell Transplant 18 2009 111 118
49. W. Prather Pluristem therapeutics Inc. Regen Med 3 2008 117 122